Mthera Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Mthera Pharma General Information

Description

Developer of a pre-clinical drug intended to accelerate the translation of innovative science into transformative precision medicine. The company's lead compounds accelerate a multi-target disease approach, enabling doctors to tackle Parkinson's and dementia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 102, 38 Magokjungang 8-ro 1-gil
  • Gangseo-gu
  • Seoul, 07793
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Number 102, 38 Magokjungang 8-ro 1-gil
  • Gangseo-gu
  • Seoul, 07793
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mthera Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 25-Oct-2023 Completed Generating Revenue
7. Early Stage VC (Series B1) 01-Aug-2022 Completed Generating Revenue
6. Early Stage VC (Series B) 24-Dec-2021 Completed Generating Revenue
5. Early Stage VC (Series A) 31-Mar-2021 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
3. Seed Round 17-Jun-2020 Completed Generating Revenue
2. Accelerator/Incubator 12-Jun-2020 Completed Generating Revenue
1. Seed Round 04-Mar-2020 Completed Startup
To view Mthera Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mthera Pharma Patents

Mthera Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023239175-A1 Composition for preventing or treating alphaherpesvirus, gammaherpesvirus or norovirus infectious disease comprising extract of tsuga sieboldii, potentilla discolor bunge, potentilla nivea l., hydrocotyle yabei makino, or anthriscus sylvestris Inactive 08-Jun-2022
WO-2023214819-A1 Composition for preventing or treating psoriasis comprising isatidis folium extract Inactive 04-May-2022
EP-4458366-A1 Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica Pending 27-Dec-2021
EP-4458366-A4 Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica Pending 27-Dec-2021
US-20240342235-A1 Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshurica Pending 27-Dec-2021 A23K10/30
To view Mthera Pharma’s complete patent history, request access »

Mthera Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mthera Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daepyung Corporation Minority
Genaxis (Korea) Venture Capital Minority
TONY Investment Venture Capital Minority
Woori Technology Investment Company Venture Capital Minority
COMEUP STARS Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Mthera Pharma FAQs

  • When was Mthera Pharma founded?

    Mthera Pharma was founded in 2020.

  • Where is Mthera Pharma headquartered?

    Mthera Pharma is headquartered in Seoul, South Korea.

  • What is the size of Mthera Pharma?

    Mthera Pharma has 6 total employees.

  • What industry is Mthera Pharma in?

    Mthera Pharma’s primary industry is Drug Discovery.

  • Is Mthera Pharma a private or public company?

    Mthera Pharma is a Private company.

  • What is Mthera Pharma’s current revenue?

    The current revenue for Mthera Pharma is .

  • How much funding has Mthera Pharma raised over time?

    Mthera Pharma has raised $11.2K.

  • Who are Mthera Pharma’s investors?

    Daepyung, Genaxis (Korea), TONY Investment, Woori Technology Investment Company, and COMEUP STARS are 5 of 9 investors who have invested in Mthera Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process